- Home
- ALXO vs DSY Comparison
ALXO vs DSY Comparison
Compare ALXO & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- DSY
- Stock Information
- Founded
- ALXO 2015
- DSY 2020
- Country
- ALXO United States
- DSY China
- Employees
- ALXO N/A
- DSY N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- DSY
- Sector
- ALXO Health Care
- DSY
- Exchange
- ALXO Nasdaq
- DSY Nasdaq
- Market Cap
- ALXO 76.5M
- DSY 73.6M
- IPO Year
- ALXO 2020
- DSY N/A
- Fundamental
- Price
- ALXO $0.66
- DSY $1.10
- Analyst Decision
- ALXO Strong Buy
- DSY
- Analyst Count
- ALXO 6
- DSY 0
- Target Price
- ALXO $4.14
- DSY N/A
- AVG Volume (30 Days)
- ALXO 1.4M
- DSY 204.5K
- Earning Date
- ALXO 03-06-2025
- DSY 02-10-2025
- Dividend Yield
- ALXO N/A
- DSY N/A
- EPS Growth
- ALXO N/A
- DSY 120.37
- EPS
- ALXO N/A
- DSY 0.01
- Revenue
- ALXO N/A
- DSY $7,323,356.00
- Revenue This Year
- ALXO N/A
- DSY N/A
- Revenue Next Year
- ALXO N/A
- DSY N/A
- P/E Ratio
- ALXO N/A
- DSY $89.28
- Revenue Growth
- ALXO N/A
- DSY 16.37
- 52 Week Low
- ALXO $0.65
- DSY $0.75
- 52 Week High
- ALXO $17.83
- DSY $13.47
- Technical
- Relative Strength Index (RSI)
- ALXO 33.23
- DSY 36.73
- Support Level
- ALXO $0.65
- DSY $0.98
- Resistance Level
- ALXO $0.74
- DSY $1.41
- Average True Range (ATR)
- ALXO 0.07
- DSY 0.18
- MACD
- ALXO -0.00
- DSY 0.01
- Stochastic Oscillator
- ALXO 0.54
- DSY 28.30
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.